The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production
Abstract
Although microRNA (miRNA) regulation of TLR signaling is well established, this has not yet been observed for NLR proteins or the inflammasomes they form. We have now validated a highly conserved miR-223 target site in the NLRP3 3′-untranslated region. miR-223 expression decreases as monocytes differentiate into macrophages, whereas NLRP3 protein increases during this time. However, overexpression of miR-223 prevents accumulation of NLRP3 protein and inhibits IL-1β production from the inflammasome. Virus inhibition of the inflammasome is an emerging theme, and we have also identified an EBV miRNA that can target the miR-223 binding site in the NLRP3 3′-untranslated region. Furthermore, this virus miRNA can be secreted from infected B cells via exosomes to inhibit the NLRP3 inflammasome in noninfected cells. Therefore, we have identified both the first endogenous miRNA that limits NLRP3 inflammatory capacity during myeloid cell development and also a viral miRNA that takes advantage of this, limiting inflammation for its own purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, miR-223 deficiency results in persistent NLRP3 and IL-1β activation and exacerbates lung injury 88.”
From miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation (2021) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The impact of microRNAs on protein output
Baek, D., Villén, J., Shin, C., Camargo, F. D., Gygi, S. P., & Bartel, D. P. (2008) · Nature · doi:10.1038/nature07242 · Cited by 3,592
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., & Lund, A. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707224200 · Cited by 1,141
Cheng, S.-C., van de Veerdonk, F. L., Lenardon, M., Stoffels, M., Plantinga, T., Smeekens, S., Rizzetto, L., Mukaremera, L., Preechasuth, K., Cavalieri, D., et al. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1210702 · Cited by 191
Research works printed but not linked: 12
- O’Neill, 2011, MicroRNAs: the fine-tuners of Toll-like receptor signalling, Nat. Rev. Immunol., 11, 163, 10.1038/nri2957 · DOI · Paper page
- Bauernfeind, 2009, Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression, J. Immunol., 183, 787, 10.4049/jimmunol.0901363 · DOI · Paper page
- Mathonnet, 2007, MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F, Science, 317, 1764, 10.1126/science.1146067 · DOI · Paper page
- Guarda, 2011, Differential expression of NLRP3 among hematopoietic cells, J. Immunol., 186, 2529, 10.4049/jimmunol.1002720 · DOI · Paper page
- Johnnidis, 2008, Regulation of progenitor cell proliferation and granulocyte function by microRNA-223, Nature, 451, 1125, 10.1038/nature06607 · DOI · Paper page
- Pegtel, 2010, Functional delivery of viral miRNAs via exosomes, Proc. Natl. Acad. Sci. USA, 107, 6328, 10.1073/pnas.0914843107 · DOI · Paper page
- Savina, 2003, Exosome release is regulated by a calcium-dependent mechanism in K562 cells, J. Biol. Chem., 278, 20083, 10.1074/jbc.M301642200 · DOI · Paper page
- Ichinohe, 2010, Influenza virus activates inflammasomes via its intracellular M2 ion channel, Nat. Immunol., 11, 404, 10.1038/ni.1861 · DOI · Paper page
- Netea, 2009, Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages, Blood, 113, 2324, 10.1182/blood-2008-03-146720 · DOI · Paper page
- Yao, 2001, Interleukin-18 expression induced by Epstein-Barr virus-infected cells, J. Leukoc. Biol., 69, 779, 10.1189/jlb.69.5.779 · doi:10.1189/jlb.69.5.779
- Krauer, 1998, Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP, Virology, 252, 418, 10.1006/viro.1998.9441 · doi:10.1006/viro.1998.9441
- Kanneganti, 2010, Central roles of NLRs and inflammasomes in viral infection, Nat. Rev. Immunol., 10, 688, 10.1038/nri2851 · DOI · Paper page
Cited by
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
Murray, D. D., Suzuki, K., Law, M., Trebicka, J., Neuhaus, J., Wentworth, D., Johnson, M., Vjecha, M. J., Kelleher, A. D., Emery, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139981 · Cited by 2,740
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885
Extracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
Pathophysiology of Atherosclerosis
Jebari-Benslaiman, S., Galicia-García, U., Larrea-Sebal, A., Olaetxea, J. R., Alloza, I., Vandenbroeck, K., Benito-Vicente, A., & Martín, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063346 · Cited by 1,010
Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
Mori, M. A., Ludwig, R. G., Garcia-Martin, R., Brandão, B. B., & Kahn, C. R. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.07.011 · Cited by 961
Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Abais, J. M., Xia, M., Zhang, Y., Boini, K. M., & Li, P.-L. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.5994 · Cited by 928
NLRP3 inflammasome and its inhibitors: a review
Shao, B.-Z., Xu, Z.-Q., Han, B.-Z., Su, D.-F., & Liu, C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00262 · Cited by 836
“MicroRNA-223 binds to a conserved site in the 3′ UTR of the NLRP3 transcript, suppressing protein expression and thereby inhibiting NLRP3 inflammasome priming and IL-1β production (Bauernfeind et al., 2012; Haneklaus et al., 2012; Chen and Sun, 2013).”
Mechanism of NLRP3 inflammasome activation
Sutterwala, F. S., Haasken, S., & Cassel, S. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12458 · Cited by 736
Exosomes and other extracellular vesicles in host–pathogen interactions
Schorey, J. S., Cheng, Y., Singh, P. P., & Smith, V. L. (2015) · EMBO reports · doi:10.15252/embr.201439363 · Cited by 727
Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing
Kharaziha, M., Baidya, A., & Annabi, N. (2021) · Advanced Materials · doi:10.1002/adma.202100176 · Cited by 721
Epstein-Barr virus: Biology and clinical disease
Damania, B., Kenney, S. C., & Raab-Traub, N. (2022) · Cell · doi:10.1016/j.cell.2022.08.026 · Cited by 612
Epstein–Barr virus infection and nasopharyngeal carcinoma
Tsao, S. W., Tsang, C. M., & Lo, K. W. (2017) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0270 · Cited by 606
Blevins, H. M., Xu, Y., Biby, S., & Zhang, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879021 · Cited by 587
Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine
Fais, S., O’Driscoll, L., Borras, F. E., Buzas, E., Camussi, G., Cappello, F., Carvalho, J., Cordeiro da Silva, A., Del Portillo, H., El Andaloussi, S., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b08015 · Cited by 481
Noncoding RNAs, cytokines, and inflammation-related diseases
Marques-Rocha, J. L., Samblas, M., Milagro, F. I., Bressan, J., Martínez, J. A., & Marti, A. (2015) · The FASEB Journal · doi:10.1096/fj.14-260323 · Cited by 477
Song, H., Liu, B., Huai, W., Yu, Z., Wang, W., Zhao, J., Han, L., Jiang, G., Zhang, L., Gao, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13727 · Cited by 451
Interleukin-1 Beta—A Friend or Foe in Malignancies?
Bent, R., Moll, L., Grabbe, S., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082155 · Cited by 444
NLRP3 Inflammasome—A Key Player in Antiviral Responses
Zhao, C., & Zhao, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00211 · Cited by 432
miR‐223: infection, inflammation and cancer
Haneklaus, M., Gerlic, M., O'Neill, L. A. J., & Masters, S. L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12099 · Cited by 423
Self-citationEpstein–Barr virus latent genes
Kang, M.-S., & Kieff, E. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.84 · Cited by 361
Deiuliis, J. A. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.170 · Cited by 349
Wang, X., Gu, H., Qin, D., Yang, L., Huang, W., Essandoh, K., Wang, Y., Caldwell, C. C., Peng, T., Zingarelli, B., et al. (2015) · Scientific Reports · doi:10.1038/srep13721 · Cited by 337
Saleh, B., Dhaliwal, H. K., Portillo‐Lara, R., Shirzaei Sani, E., Abdi, R., Amiji, M. M., & Annabi, N. (2019) · Small · doi:10.1002/smll.201902232 · Cited by 323
MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment
Dorhoi, A., Iannaccone, M., Farinacci, M., Faé, K. C., Schreiber, J., Moura-Alves, P., Nouailles, G., Mollenkopf, H.-J., Oberbeck-Müller, D., Jörg, S., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67604 · Cited by 293
Update on Epstein-Barr virus and gastric cancer (Review)
SHINOZAKI-USHIKU, A., KUNITA, A., & FUKAYAMA, M. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2856 · Cited by 286
Toward targeting inflammasomes: insights into their regulation and activation
Christgen, S., Place, D. E., & Kanneganti, T.-D. (2020) · Cell Research · doi:10.1038/s41422-020-0295-8 · Cited by 281
microRNA target prediction programs predict many false positives
Pinzón, N., Li, B., Martinez, L., Sergeeva, A., Presumey, J., Apparailly, F., & Seitz, H. (2017) · Genome Research · doi:10.1101/gr.205146.116 · Cited by 273
EBV-positive diffuse large B-cell lymphoma of the elderly
Ok, C. Y., Papathomas, T. G., Medeiros, L. J., & Young, K. H. (2013) · Blood · doi:10.1182/blood-2013-03-489708 · Cited by 260
MicroRNAs: New Regulators of Toll-Like Receptor Signalling Pathways
He, X., Jing, Z., & Cheng, G. (2014) · BioMed Research International · doi:10.1155/2014/945169 · Cited by 238
The Role of Microglia and the Nlrp3 Inflammasome in Alzheimer's Disease
Hanslik, K. L., & Ulland, T. K. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.570711 · Cited by 236
MicroRNAs: Roles in Regulating Neuroinflammation
Gaudet, A. D., Fonken, L. K., Watkins, L. R., Nelson, R. J., & Popovich, P. G. (2018) · The Neuroscientist · doi:10.1177/1073858417721150 · Cited by 236
Huai, W., Zhao, R., Song, H., Zhao, J., Zhang, L., Zhang, L., Gao, C., Han, L., & Zhao, W. (2014) · Nature Communications · doi:10.1038/ncomms5738 · Cited by 211
HIV-1 tat primes and activates microglial NLRP3 inflammasome-mediated neuroinflammation.
Chivero, E. T., Guo, M.-L., Periyasamy, P., Liao, K., Callen, S. E., & Buch, S. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3045-16.2017 · Cited by 201
miR-223: An Effective Regulator of Immune Cell Differentiation and Inflammation
Jiao, P., Wang, X.-P., Luoreng, Z.-M., Yang, J., Jia, L., Ma, Y., & Wei, D.-W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59876 · Cited by 151
MiR-223-3p inhibits rTp17-induced inflammasome activation and pyroptosis by targeting NLRP3
Long, F., Kou, C., Li, K., Wu, J., & Wang, Q. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16061 · Cited by 87
miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages
Nguyen, M.-A., Hoang, H.-D., Rasheed, A., Duchez, A.-C., Wyatt, H., Cottee, M. L., Graber, T. E., Susser, L., Robichaud, S., Berber, İ., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319120 · Cited by 74
NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease
Guan, Y., Gu, Y., Li, H., Liang, B., Han, C., Zhang, Y., Liu, Q., Wei, W., & Ma, Y. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022137 · Cited by 48
Zhang, Q.-B., Zhu, D., Dai, F., Huang, Y.-Q., Zheng, J.-X., Tang, Y.-P., Dong, Z.-R., Liao, X., & Qing, Y.-F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.637415 · Cited by 45
Metadata
- Authors
- Haneklaus, M., Gerlic, M., Kurowska-Stolarska, M., Rainey, A.-A., Pich, D., McInnes, I. B., Hammerschmidt, W., O’Neill, L. A. J., & Masters, S. L.
- Affiliations
- Inflammation Research Group and Immunology Research Centre, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin , Dublin 4,
- Inflammation Division, The Walter and Eliza Hall Institute , Melbourne, Victoria 3052,
- Institute of Infection, Immunity and Inflammation, University of Glasgow , Glasgow G12 8TA,
- Department of Gene Vectors, Helmholtz Center Munich , Munich 81377,
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-10
- Volume
- 189
- Issue
- 8
- Pages
- 3795-3799
- ISSN
- 0022-1767
- 1550-6606
- Cited by
- 411
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.